RENE — ReNeuron Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
REG - ReNeuron Group plc - Signs retinal stem cell exclusivity agreement
AnnouncementREG - ReNeuron Group plc - Notification of Preliminary Results
AnnouncementREG - ReNeuron Group plc - Capital Markets Event
AnnouncementREG - ReNeuron Group plc - Exosome data presented at ISCT conference
AnnouncementREG - ReNeuron Group plc - Capital Markets Event and Webcast
AnnouncementREG - ReNeuron Group plc - Wins grant for retinal cell therapy development
AnnouncementREG - ReNeuron Group plc - Appointment of US-based Chief Medical Officer
AnnouncementREG - ReNeuron Group plc - Product Development Update
AnnouncementREG - ReNeuron Group plc - Block Listing Review and TVR <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Block Listing Application <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Positive pre-clinical data in nerve injury <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementRCS - ReNeuron Group plc - Phase II stroke data presented at AHA conference <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Approval of Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Further re Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Proposed Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Interim results <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Stroke clinical trial regulatory approval in US <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - ReNeuron opens US office <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Notification of Interim Results <Origin Href="QuoteRef">RQE.L</Origin>
Announcement